Activity in this selectiondcvc-91823141
- Rounds participated in
- 2
- Confirmed lead rounds
- —
2 roles undisclosed- New companies
- 2
First participation on record · 0 follow-on- Funding in participating rounds
- $44M
2 disclosed · full round size, not this investor’s share
Rounds
2 in this selectionPrenosisDevelops integrated diagnostics and therapeutics for critical care conditions
Role not disclosedAntheiaProvides advanced biosynthesis for pharmaceutical manufacturing and innovation
Role not disclosed